de Walque D
Development Research Group, The World Bank, 1818 H Street, NW Washington, DC 20433, USA.
Sex Transm Infect. 2008 Apr;84(2):122-5. doi: 10.1136/sti.2007.028167. Epub 2008 Jan 11.
Although sexual transmission is generally considered to be the main factor driving the HIV/AIDS epidemic in Africa, recent studies have claimed that iatrogenic transmission should be considered as an important source of HIV infection. In particular, receipt of tetanus toxoid injections during pregnancy has been reported to be associated with HIV infection in Kenya. The objective of this paper is to assess the robustness of this association among women in nationally representative HIV surveys in seven African countries.
The association between prophylactic tetanus toxoid injections during pregnancy and HIV infection was analysed, using individual-level data from women who gave birth in the past five years. These data are from the nationally representative Demographic and Health Surveys, which included HIV testing in seven African countries: Burkina Faso 2003 (N = 2424), Cameroon 2004 (N = 2600), Ethiopia 2005 (N = 2886), Ghana 2003 (N = 2560), Kenya 2003 (N = 1617), Lesotho 2004 (N = 1278) and Senegal 2005 (N = 2126).
Once the odds ratios (OR) were adjusted for five-year age groups and for ethnic, urban and regional indicators, the association between prophylactic tetanus toxoid injections during pregnancy and HIV infection was never statistically significant in any of the seven countries. Only in Cameroon was there an association between previous tetanus toxoid injection and HIV positivity but it became weaker (OR 1.53, 95% CI 0.91 to 2.57) once urban location and ethnic group were adjusted for.
Although the risk of HIV infection through unsafe injections and healthcare should not be ignored and should be reduced, it does not seem that there is, at present and in the seven countries studied, strong evidence supporting the claim that unsafe tetanus toxoid injections are a major factor driving the HIV epidemic.
尽管性传播通常被认为是推动非洲艾滋病毒/艾滋病流行的主要因素,但最近的研究声称,医源性传播应被视为艾滋病毒感染的一个重要来源。特别是,据报道,在肯尼亚,孕期接受破伤风类毒素注射与艾滋病毒感染有关。本文的目的是在七个非洲国家具有全国代表性的艾滋病毒调查中,评估女性中这种关联的稳健性。
利用过去五年内分娩女性的个体层面数据,分析孕期预防性破伤风类毒素注射与艾滋病毒感染之间的关联。这些数据来自具有全国代表性的人口与健康调查,该调查在七个非洲国家开展了艾滋病毒检测:2003年的布基纳法索(N = 2424)、2004年的喀麦隆(N = 2600)、2005年的埃塞俄比亚(N = 2886)、2003年的加纳(N = 2560)、2003年的肯尼亚(N = 1617)、2004年的莱索托(N = 1278)和2005年的塞内加尔(N = 2126)。
一旦对五岁年龄组以及种族、城市和地区指标进行比值比(OR)调整后,在这七个国家中的任何一个国家,孕期预防性破伤风类毒素注射与艾滋病毒感染之间的关联在统计学上均无显著性。仅在喀麦隆,既往破伤风类毒素注射与艾滋病毒阳性之间存在关联,但在对城市位置和种族进行调整后,这种关联变弱了(OR 1.53,95%可信区间0.91至2.57)。
尽管通过不安全注射和医疗保健感染艾滋病毒的风险不应被忽视,且应予以降低,但目前在所研究的七个国家中,似乎没有有力证据支持不安全的破伤风类毒素注射是推动艾滋病毒流行的主要因素这一说法。